Immunotherapy of cytomegalovirus infection after stem-cell transplantation: a new option?

Lancet. 2003 Oct 25;362(9393):1343-4. doi: 10.1016/S0140-6736(03)14673-9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents / adverse effects
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Cytomegalovirus / drug effects
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / therapy*
  • Ganciclovir / adverse effects
  • Ganciclovir / pharmacology
  • Ganciclovir / therapeutic use
  • Humans
  • Immunocompromised Host / immunology
  • Immunotherapy / methods*
  • Postoperative Complications / drug therapy
  • Postoperative Complications / therapy*
  • Stem Cell Transplantation*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / transplantation

Substances

  • Antiviral Agents
  • Ganciclovir